In other recent news, Cassava Sciences announced a significant development with the acquisition of an exclusive license for a treatment patent related to its drug candidate, simufilam. The patent ...

In other recent news, Cassava Sciences announced a significant development with the acquisition of an exclusive license for a treatment patent related to its drug candidate, simufilam. The patent, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Cassava Sciences, Inc. (NASDAQ:SAVA – Free Report) – Analysts at HC Wainwright increased their FY2025 earnings per share (EPS) estimates for shares of Cassava Sciences in a research note ...

After hours: March 12 at 7:57:01 PM EDT Loading Chart for SAVA ...

Mar. 10, 2025 — Feral cats have long been suspects in killing native species reintroduced into Australian conservation areas. DNA testing of the carcasses puts ... The Yucca and the Moth: How ...